Multi-level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients

Our results show that the added prognostic value of binary proliferation-related gene signatures is limited for Ki67-assessed breast cancers. More complex, multi-level descriptions have a greater potential in short- and long-term prognostication for biologically relevant breast cancer subgroups.